HarryMSchragerMD

Infectious Disease • Newton, MA

Assistant Clinical Professor of Medicine

Join to view full profile

Dr. Schrager is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schrager's full profile

Already have an account?

Office
2000 Washington St
320-Blue
Newton, MA 02462
Phone+1 617-243-6597

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1994 - 1997
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1991 - 1994
Rutgers New Jersey Medical SchoolClass of 1991

Certifications & Licensure

MA State Medical License 1993 - 2025
RI State Medical License 1999 - 2004
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

AOA 1990

Clinical Trials

Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
Completed
Phase 2, Phase 3
Roles: Contact

Publications & Presentations

PubMed

123 citations
Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes.
Harry M. Schrager, Sebastián Albertí, Colette Cywes, G J Dougherty, Michael R. Wessels
The Journal of Clinical Investigation. 1998-04-15
158 citations
Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.
Harry M. Schrager, James G. Rheinwald, Michael R. Wessels
The Journal of Clinical Investigation. 1996-11-01
2 citations
Infectious occupational exposures in dermatology--a review of risks and prevention measures. II. The pregnant dermatologist.
Sarita Nori, Mary Ann Greene, Harry M Schrager, Vincent Falanga
Journal of the American Academy of Dermatology. 2005-12-01

Journal Articles

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan M Lockwood, Mich..., The New England Journal of Medicine

Press Mentions

Old Drug, New Trick? The Rationale for the Treatment of COVID-19 with Activated Protein CFebruary 16th, 2021
Councilors, Medical Experts Push for More in-Person Learning at Newton SchoolsJanuary 12th, 2021